Heron Therapeutics | HRTX - ДОЛГ





ДОЛГ Изменить Дата
ALKERMES USD 1.58B 1.51B 2026-03
Alnylam Pharmaceuticals USD 1.28B 30.06M 2025-12
Amarin USD 0 0 2025-03
ANI Pharmaceuticals USD 617.04M 3.28M 2025-12
Anika Therapeutics USD 0 0 2025-03
Arrowhead Research USD 312.77M 53.52M 2025-12
Eisai JPY 236.67B 49.14B 2025-09
Emergent BioSolutions USD 903.2M 495.2M 2023-06
Esperion Therapeutics USD 262.92M 1.76M 2024-09
GlaxoSmithKline GBP 19.06B 1.34B 2026-03
Heron Therapeutics USD 149.65M 157K 2024-09
Insmed USD 727.62M 275K 2026-03
Ligand Pharmaceuticals USD 451.49M 494K 2025-12
Merck USD 49.34B 7.97B 2025-12
Nektar Therapeutics USD 0 0 2022-06
Neurocrine Biosciences USD 406.2M 9.1M 2026-03
Omeros USD 442.16M 199K 2023-09
Pacira USD 367.66M 4.53M 2026-03
Regeneron Pharmaceuticals USD 2.71B 300K 2026-03
Roche Holding CHF 33.03B 1.41B 2025-06
Sangamo BioSciences USD 0 0 2022-06
Ultragenyx Pharmaceutical USD 36M 2.17M 2025-12
Veracyte USD 39.65M 799K 2025-12
Vertex Pharmaceuticals USD 1.99B 44M 2026-03